MOUNTAIN VIEW, CA — (Marketwired) — 10/30/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the Sensei X2 Robotic System is commercially available in the U.S. and European Union. Sensei X2 is a technological leap forward; featuring faster processing speeds, enhanced image integration, and a lower profile design. Launch of Sensei X2 is a key milestone as Hansen continues to deliver on its pipeline of innovative robotic platforms for electroph
MOUNTAIN VIEW, CA — (Marketwired) — 10/21/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first robot-assisted Uterine Fibroid Embolization (UFE) in the United States. Sandeep Rao, MD, Interventional Radiologist, performed the procedure at Sierra Medical Center in El Paso, Texas using the Magellan Robotic System."I am extremely pleased by the outcome of this initial procedure," said Dr. Rao. "Robotic ca
MOUNTAIN VIEW, CA — (Marketwired) — 10/20/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it has named Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs. Mr. Sheahan will report directly to Hansen–s President and Chief Executive Officer, Cary Vance."I–m delighted to announce Brian–s appointment as Vice President of Clinical, Regulatory and Quality Affairs," said Cary Vance, CEO. "Brian brings ext
MOUNTAIN VIEW, CA — (Marketwired) — 09/17/14 — A study, published online ahead of print in , concluded that using Hansen Medical, Inc.–s (NASDAQ: HNSN) Sensei® Robotic System with the Thermocool® SmartTouch® Catheter (BioSense Webster, Diamond Bar, CA) for persistent atrial fibrillation is associated with statistically significant improved success rates when compared with manual ablation with Thermocool SmartTouch. The study found that a combination of remote robotic navigation
MOUNTAIN VIEW, CA — (Marketwired) — 11/25/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that Chief Financial Officer, Peter J. Mariani, is scheduled to present at the 25th Annual Piper Jaffray Healthcare Conference. The conference is being held December 3-4, 2013 at the Palace Hotel in New York, NY. Hansen Medical is scheduled to present on Wednesday, December 4, 2013 at 3:30 p.m. Eastern Time.Hansen Medical will provide a live webcast o
MOUNTAIN VIEW, CA — (Marketwired) — 11/13/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the 40th Annual VEITHsymposium from November 19th-23rd at the Hilton New York in New York City. The Company will be conducting product demonstrations and exhibiting the Magellan Robotic System at Booth 201.Multiple presentations and physician panel sessions discussing the growing body of compelling clinic
MOUNTAIN VIEW, CA — (Marketwired) — 11/11/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that President and CEO, Bruce Barclay, is scheduled to present at the Barclays Select Series 2013: Select Growth Conference. The conference is being held November 18 – 20, 2013 in New York, NY. Hansen Medical is scheduled to present on Monday, November 18, 2013 at 9:05 a.m. Eastern Time.Hansen Medical will provide a live webcast of the audio presentat
Third Quarter Revenue of $5.1 Million; Shipped Five Robotic Systems in the Quarter; Commercialized Four Robotic Systems in the Quarter, and One Additional System in October, Bringing the Year-to-Date Total to Nine; Growth in Estimated Procedures Performed of 14% Quarterly, and 24% Year Over Year
MOUNTAIN VIEW, CA — (Marketwired) — 10/28/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that Dr. Barry Katzen, founder and Medical Director of Baptist Cardiac & Vascular Institute (Baptist Hospital of Miami), is scheduled to utilize the Magellan Robotic System in a live endovascular aneurysm repair (EVAR) case at the Transcatheter Cardiovascular Therapeutics (TCT) conference in the Main Arena II at the Moscone Center in San Francisco
